Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Higuchi John W., holds the title of Director at Lipocine Inc..
On 2026-11-19, the insider transacted 150,000 shares.The shares were transacted at a weighted average price of $1.50 per share, resulting in a total market-relevant value of $225K.
Higuchi John W. (Director) bought $225K of $LPCN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.